Design, Synthesis and Evaluation of Praziquantel Analogues and New Molecular Hybrids as Potential Antimalarial and Anti-Schistosomal Agents
Molecules · 2023
DOI: 10.3390/molecules28135184 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Freddy Mugisho Kasago und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Physical Sciences, Faculty of Natural Sciences, Walter Sisulu University, Nelson Mandela Drive, Mthatha 5117, South Africa. Hauptthemen laut MEDLINE: Antimalarials, Schistosomicides, Schistosomiasis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Walter Sisulu University, The Directorate of Research and Innovation of Walter Sisulu University, Creppat Laboratories.
Abstract (Originalsprache)
Malaria and schistosomiasis are two of the neglected tropical diseases that persistently wreak havoc worldwide. Although many antimalarial drugs such as chloroquine are readily available, the emergence of drug resistance necessitates the development of new therapies to combat this disease. Conversely, Praziquantel (PZQ) remains the sole effective drug against schistosomiasis, but its extensive use raises concerns about the potential for drug resistance to develop. In this project, the concept of molecular hybridization was used as a strategy to design the synthesis of new molecular hybrids with potential antimalarial and antischistosomal activity. A total of seventeen molecular hybrids and two PZQ analogues were prepared by coupling 6-alkylpraziquanamines with cinnamic acids and cyclohexane carboxylic acid, respectively. The synthesised compounds were evaluated for their antimalarial and antischistosomal activity; while all of the above compounds were inactive against Plasmodium falciparum (IC50 > 6 µM), many were active against schistosomiasis with four particular compounds exhibiting up to 100% activity against newly transformed schistosomula and adult worms at 50 µM. Compared to PZQ, the reference drug, the activity of which is 91.7% at 1 µM, one particular molecular hybrid, compound 32, which bears a para-isopropyl group on the cinnamic acid moiety, exhibited a notable activity at 10 µM (78.2% activity). This compound has emerged as the front runner candidate that might, after further optimization, hold promise as a potential lead compound in the fight against schistosomiasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Physical Sciences, Faculty of Natural Sciences, Walter Sisulu University, Nelson Mandela Drive, Mthatha 5117, South Africa.
- Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Kreuzstr. 2, CH-4123 Allschwil, Switzerland.
ORCID-Profile: Jennifer Keiser, Wayiza Masamba
Förderung
- Walter Sisulu University
- The Directorate of Research and Innovation of Walter Sisulu University
- Creppat Laboratories
- Swiss National Science Foundation
Zitieren
APA
Kasago, F. M., Häberli, C., Keiser, J., & Masamba, W. (2023). Design, Synthesis and Evaluation of Praziquantel Analogues and New Molecular Hybrids as Potential Antimalarial and Anti-Schistosomal Agents. Molecules. https://doi.org/10.3390/molecules28135184
Vancouver
Kasago FM, Häberli C, Keiser J, Masamba W. Design, Synthesis and Evaluation of Praziquantel Analogues and New Molecular Hybrids as Potential Antimalarial and Anti-Schistosomal Agents. Molecules. 2023. doi:10.3390/molecules28135184
BibTeX
@article{Kasago2023,
author = {Kasago, Freddy Mugisho and Häberli, Cécile and Keiser, Jennifer and Masamba, Wayiza},
title = {Design, Synthesis and Evaluation of Praziquantel Analogues and New Molecular Hybrids as Potential Antimalarial and Anti-Schistosomal Agents},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28135184}
}
EUVIMED